NASDAQ: OPGNOpgen Inc Stock Ownership - Who owns Opgen?
Insider buying vs selling
Have Opgen Inc insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.
Be the first to know when OPGN insiders and whales buy or sell their stock.
OPGN Shareholders
What type of owners hold Opgen Inc stock?
Institutional
Insider
Retail
| Name | Hold | Shares | Value | Type |
|---|---|---|---|---|
| Jven Capital LLC | 92.83% | 5,680,604 | $3.92M | Insider |
| Merck Co Inc | 88.46% | 5,413,449 | $3.74M | Insider |
| Versant Ventures Iii LLC | 41.74% | 2,554,211 | $1.76M | Insider |
| Brian G. Atwood | 41.74% | 2,554,211 | $1.76M | Insider |
| Misti Ushio | 23.05% | 1,410,624 | $973.33k | Insider |
| 180 Degree Capital Corp | 23.04% | 1,409,796 | $972.76k | Insider |
| Evan Jones | 11.25% | 688,731 | $475.22k | Insider |
| Timothy Howe | 6.35% | 388,328 | $267.95k | Insider |
| Timothy Harris Jr. | 1.46% | 89,408 | $61.69k | Insider |
| Kevin Krenitsky | 0.85% | 52,050 | $35.91k | Insider |
OPGN vs Diagnostic & Research Stocks
Opgen Stock Ownership FAQ
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.